Evaluation of the Safety and Pharmacokinetics of Dinutuximab Beta As Maintenance Therapy in Chinese Participants With High-Risk Neuroblastoma
Clinical trial NCT05373901 · COMPLETED
Trial details
- NCT number
- NCT05373901
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-07
- Primary completion
- 2023-06-29
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.